17.2
Mirum Pharmaceuticals, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
64.7
FY23:
139
FY24:
255
FY25:
421
(positive)
Change from FY21 to FY25
millions USD
FY21:
−175
FY22:
−144
FY23:
−156
FY24:
−169
FY25:
−122
(positive)
Change from FY21 to FY25
millions USD
FY21:
−65.0
FY22:
−124
FY23:
−87.4
FY24:
−49.0
FY25:
17.2
(positive)
Change from FY21 to FY25
millions USD
FY21:
−84.0
FY22:
−142
FY23:
−162
FY24:
−86.9
FY25:
−21.4
(positive)
Change from FY21 to FY25
millions USD
FY21:
−84.0
FY22:
−136
FY23:
−163
FY24:
−87.9
FY25:
−23.4
All amounts in millions USD